Insider · CIK 0002097951
Christopher Gerry
Files at FTH (Sensei Biotherapeutics, Inc.). First filing -, latest -.
In brief
Christopher Gerry files SEC Form 4 as president at FTH (Sensei Biotherapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Christopher Gerry has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 10, 2026 | FTH Sensei Biotherapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +220,000 | $0.00 | $0 | 220,000 | Jun 12, 2026 |
Questions about Christopher Gerry
Answered from the filings on this page, as of the latest one.
Is Christopher Gerry buying or selling?
Christopher Gerry has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Christopher Gerry's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Christopher Gerry has 0.
Where does Christopher Gerry file Form 4?
Christopher Gerry has filed Form 4 at FTH (Sensei Biotherapeutics, Inc.) as President & PEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.